Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States.
Pulm Circ
; 14(2): e12326, 2024 Apr.
Article
em En
| MEDLINE
| ID: mdl-38623409
ABSTRACT
Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication users to identify predictors of treatment discontinuation. Treatment by accredited pulmonary hypertension centers and combination therapy with PAH agents from different classes were less likely to result in discontinuation.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article